Possible anti-atherogenic effects of emodin [mycotoxin], an anthraquinone from Chinese herbs and Aspergillus and Penicillium fungi
2002
Nagashima, H. (National Food Research Inst., Tsukuba, Ibaraki (Japan)) | Nakamura, K. | Goto, T.
Possible anti-atherogenic actkities of emodin were found. In this study, we investigated the effects of emodin on monocyte chemotactic protein (MCP)-1 and tissue inhibitor of metalloproteinases (TIMP)-2 secretion using aortic smooth muscle cell A-10. Both of them are considered to play important roles in the pathogenesis of atherosclerosis. Emodin had a dose-dependent inhibitory effect on tumor necrosis factor-a induced MCP-1 secretion. Exposure to 50 and 100 micrM emodin caused significant inhibition of TIMP-2 secretion. These results suggested that emodin has an anti-atherogenic potential. Also, the estrogenic activity of emodin was investigated. Emodin competed against estrogen in estrogen receptor (ER) binding, indicating that emodin is an estrogenic mycotoxin, Seeing that estrogens also inhibit the secretion of MCP-1, ER (s) may be a mediator of the emodin's transducing signal.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par The Agriculture, Forestry and Fisheries Research Information Technology Center
Découvrez la collection de ce fournisseur de données dans AGRIS
